Pulmonary veno-occlusive disease: the bête noire of pulmonary hypertension in connective tissue diseases?

[1]  Horst Olschewski,et al.  Updated clinical classification of pulmonary hypertension. , 2009, Journal of the American College of Cardiology.

[2]  P. Hassoun,et al.  Is pulmonary arterial hypertension really a late complication of systemic sclerosis? , 2010, Chest.

[3]  M. Humbert,et al.  Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension. , 2010, European heart journal.

[4]  M. Humbert,et al.  Pulmonary veno-occlusive disease: recent progress and current challenges. , 2010, Respiratory medicine.

[5]  M. Humbert,et al.  Systemic sclerosis-associated pulmonary arterial hypertension. , 2010, American journal of respiratory and critical care medicine.

[6]  J. Pepke-Zaba.  Diagnostic testing to guide the management of chronic thromboembolic pulmonary hypertension: state of the art , 2010, European Respiratory Review.

[7]  M. Humbert,et al.  Beyond arterial remodelling: pulmonary venous and cardiac involvement in patients with systemic sclerosis-associated pulmonary arterial hypertension , 2010, European Respiratory Journal.

[8]  M. Humbert,et al.  Maladie veino-occlusive et hémangiomatose capillaire pulmonaire , 2010 .

[9]  M. Humbert,et al.  [Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis]. , 2010, Presse medicale.

[10]  M. Humbert,et al.  Implementing the ESC/ERS pulmonary hypertension guidelines: real-life cases from a national referral centre , 2009, European Respiratory Review.

[11]  M. Humbert,et al.  Goal-oriented therapy in pulmonary veno-occlusive disease: a word of caution , 2009, European Respiratory Journal.

[12]  D. Badesch,et al.  Longterm Survival Among Patients with Scleroderma-associated Pulmonary Arterial Hypertension Treated with Intravenous Epoprostenol , 2009, The Journal of Rheumatology.

[13]  G. Filippatos,et al.  Guidelines for the diagnosis and treatment of pulmonary hypertension , 2009 .

[14]  A. Manes,et al.  Pulmonary veno-occlusive disease misdiagnosed as idiopathic pulmonary arterial hypertension , 2009, European Respiratory Review.

[15]  A. Nicholson,et al.  Sarcoidosis-related pulmonary veno-occlusive disease presenting with recurrent haemoptysis , 2009, European Respiratory Journal.

[16]  M. Maitland,et al.  Inflammation, growth factors, and pulmonary vascular remodeling. , 2009, Journal of the American College of Cardiology.

[17]  M. Humbert,et al.  Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive disease , 2009, European Respiratory Journal.

[18]  M. Humbert,et al.  The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France. , 2009, Arthritis and rheumatism.

[19]  B. Dijkmans,et al.  Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy , 2009, European Respiratory Journal.

[20]  D. Rassl,et al.  Advances in the understanding and classification of pulmonary hypertension , 2009, Histopathology.

[21]  A. Nicholson,et al.  Pulmonary veno-occlusive disease presenting with recurrent pulmonary oedema and the use of nitric oxide to predict response to sildenafil , 2008, Thorax.

[22]  A. Hovnanian,et al.  Doença veno-oclusiva pulmonar: alternativas diagnósticas e terapêuticas , 2008 .

[23]  M. Humbert,et al.  Pulmonary Veno-Occlusive Disease: Clinical, Functional, Radiologic, and Hemodynamic Characteristics and Outcome of 24 Cases Confirmed by Histology , 2008, Medicine.

[24]  E. Smit,et al.  Possible role of imatinib in clinical pulmonary veno-occlusive disease , 2008, European Respiratory Journal.

[25]  P. Dartevelle,et al.  Lymph node pathology in pulmonary veno-occlusive disease and pulmonary capillary heamangiomatosis , 2008, Virchows Archiv.

[26]  Jeffrey R. Galvin,et al.  From the archives of the AFIP: pulmonary alveolar proteinosis. , 2008, Radiographics : a review publication of the Radiological Society of North America, Inc.

[27]  M. Patnaik,et al.  Pulmonary veno-occlusive disease following hematopoietic stem cell transplantation: a rare model of endothelial dysfunction , 2008, Bone Marrow Transplantation.

[28]  M. Humbert,et al.  Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases. , 2008, Arthritis and rheumatism.

[29]  D. Borderie,et al.  High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis. , 2008, Arthritis and rheumatism.

[30]  R. Souza,et al.  Pulmonary veno-occlusive disease: diagnostic and therapeutic alternatives. , 2008, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia.

[31]  M. Humbert,et al.  Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases. , 2007, Human pathology.

[32]  D. Visscher,et al.  Pulmonary veno-occlusive disease as a primary cause of pulmonary hypertension in a patient with mixed connective tissue disease , 2007, Rheumatology International.

[33]  J. Galvin,et al.  From the Archives of the AFIP: pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis. , 2007, Radiographics : a review publication of the Radiological Society of North America, Inc.

[34]  D. O’Callaghan,et al.  Combination therapy and new types of agents for pulmonary arterial hypertension. , 2007, Clinics in chest medicine.

[35]  H. Palevsky,et al.  Standard therapies for pulmonary arterial hypertension. , 2007, Clinics in chest medicine.

[36]  T. Medsger,et al.  Changes in causes of death in systemic sclerosis, 1972–2002 , 2007, Annals of the rheumatic diseases.

[37]  J. Orens,et al.  Lung transplantation in scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertension. , 2006, Arthritis and rheumatism.

[38]  Sindhu R. Johnson,et al.  Pulmonary veno-occlusive disease and scleroderma associated pulmonary hypertension. , 2006, The Journal of rheumatology.

[39]  O. Distler,et al.  Pulmonary arterial hypertension and rheumatic diseases--from diagnosis to treatment. , 2006, Rheumatology.

[40]  J. Krishnan,et al.  Clinical differences between idiopathic and scleroderma-related pulmonary hypertension. , 2006, Arthritis and rheumatism.

[41]  A. Nicholson,et al.  Pulmonary Veno-occlusive Disease and Pulmonary Capillary Hemangiomatosis: A Clinicopathologic Study of 35 Cases , 2006, The American journal of surgical pathology.

[42]  M. Humbert,et al.  Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension. , 2006, Chest.

[43]  M. Humbert,et al.  Pulmonary arterial hypertension in France: results from a national registry. , 2006, American journal of respiratory and critical care medicine.

[44]  L. Pasquier,et al.  Orphanet Journal of Rare Diseases , 2006 .

[45]  R. Wise,et al.  Natural history of mild-moderate pulmonary hypertension and the risk factors for severe pulmonary hypertension in scleroderma. , 2006, The Journal of rheumatology.

[46]  D. Doll,et al.  Vascular toxicity of antineoplastic agents. , 2006, Seminars in oncology.

[47]  M. Humbert,et al.  BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertension , 2006, Human mutation.

[48]  M. Humbert,et al.  Occult alveolar haemorrhage in pulmonary veno-occlusive disease , 2006, European Respiratory Journal.

[49]  F. Martinez,et al.  International guidelines for the selection of lung transplant candidates: 2006 update--a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. , 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[50]  M. Humbert,et al.  Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. , 2005, Arthritis and rheumatism.

[51]  M. Humbert,et al.  Drug Insight: endothelin-receptor antagonists for pulmonary arterial hypertension in systemic rheumatic diseases , 2005, Nature Clinical Practice Rheumatology.

[52]  T. Welte,et al.  Goal-oriented treatment and combination therapy for pulmonary arterial hypertension , 2005, European Respiratory Journal.

[53]  L. Memış,et al.  Pulmonary veno-occlusive disease in a patient with a history of Hashimoto's thyroiditis. , 2005, The Indian journal of chest diseases & allied sciences.

[54]  M. Mayes.  Race, scleroderma, and survival: why is there a difference? , 2005, The Journal of rheumatology.

[55]  X. Mariette,et al.  Anti-midbody antibodies as a possible predictive factor for a special limited or abortive form of systemic sclerosis? , 2005, Annals of the rheumatic diseases.

[56]  N. Ibrahim,et al.  Segmental pulmonary veno-occlusive disease secondary to lung cancer , 2005, Journal of Clinical Pathology.

[57]  A. Lopes,et al.  One-year follow-up of the effects of sildenafil on pulmonary arterial hypertension and veno-occlusive disease. , 2005, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[58]  B. Corrin,et al.  Pulmonary veno-occlusion—an complex disease? , 2005, Virchows Archiv A.

[59]  C. Wagenvoort,et al.  The pathology of pulmonary veno-occlusive disease , 2005, Virchows Archiv A.

[60]  M. Humbert,et al.  Traitement de l'hypertension artérielle pulmonaire , 2004 .

[61]  M. Humbert,et al.  Pulmonary hypertension: CT of the chest in pulmonary venoocclusive disease. , 2004, AJR. American journal of roentgenology.

[62]  R. D. du Bois,et al.  Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. , 2004, Rheumatology.

[63]  A. Garcia-Gonzalez,et al.  Therapy with intermittent pulse cyclophosphamide for pulmonary hypertension associated with systemic lupus erythematosus , 2004, Lupus.

[64]  S. Jimenez,et al.  Following the Molecular Pathways toward an Understanding of the Pathogenesis of Systemic Sclerosis , 2004, Annals of Internal Medicine.

[65]  M. Kondo,et al.  Pulmonary veno‐occlusive disease following allogeneic peripheral blood stem cell transplantation for chronic myeloid leukaemia , 2003, British journal of haematology.

[66]  R. Deterding,et al.  Pulmonary veno-occlusive disease after autologous bone marrow transplant in a child with stage IV neuroblastoma: case report and literature review. , 2003, Journal of pediatric hematology/oncology.

[67]  J. Newman,et al.  Pulmonary veno-occlusive disease caused by an inherited mutation in bone morphogenetic protein receptor II. , 2003, American journal of respiratory and critical care medicine.

[68]  S. Kimmel,et al.  Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis. , 2003, Chest.

[69]  F. Capron,et al.  Pulmonary veno-occlusive disease after neoadjuvant mitomycin chemotherapy and surgery for lung carcinoma. , 2002, Lung cancer.

[70]  É. Rich,et al.  Predicting Mortality in Systemic Sclerosis: Analysis of a Cohort of 309 French Canadian Patients with Emphasis on Features at Diagnosis as Predictive Factors for Survival , 2002, Medicine.

[71]  N. Kamatani,et al.  Pulmonary hypertension in systemic lupus erythematosus: evaluation of clinical characteristics and response to immunosuppressive treatment. , 2002, The Journal of rheumatology.

[72]  E. Ely,et al.  Pulmonary veno-occlusive disease: a case series and new observations. , 2000, Chest.

[73]  C. L. Bailey,et al.  "High probability" perfusion lung scans in pulmonary venoocclusive disease. , 2000, American journal of respiratory and critical care medicine.

[74]  Stuart Rich,et al.  Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease , 2000, Annals of Internal Medicine.

[75]  N. Narita,et al.  Pulmonary veno-occlusive disease in pulmonary Langerhans' cell granulomatosis. , 2000, The European respiratory journal.

[76]  Y. Fujii,et al.  Pulmonary hypertension associated with pulmonary occlusive vasculopathy after allogeneic bone marrow transplantation. , 2000, Transplantation.

[77]  Inda,et al.  A COMPARISON OF CONTINUOUS INTRAVENOUS EPOPROSTENOL ( PROSTACYCLIN ) WITH CONVENTIONAL THERAPY FOR PRIMARY PULMONARY HYPERTENSION , 2000 .

[78]  S. Deutscher,et al.  Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. , 1999, Arthritis and rheumatism.

[79]  S. Uwatoko,et al.  Up‐regulation of intercellular adhesion molecule‐1 (ICAM‐1), endothelial leucocyte adhesion molecule‐1 (ELAM‐1) and class II MHC molecules on pulmonary artery endothelial cells by antibodies against U1‐ribonucleoprotein , 1999, Clinical and experimental immunology.

[80]  M. Koss,et al.  Pulmonary veno-occlusive disease. , 1996, Current opinion in pulmonary medicine.

[81]  M. Hoeper,et al.  Effects of inhaled nitric oxide and aerosolized iloprost in pulmonary veno-occlusive disease. , 1999, Respiratory medicine.

[82]  L. Rubin,et al.  Primary pulmonary hypertension. , 1997, The New England journal of medicine.

[83]  T. Bashore,et al.  Massive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease. , 1998, Chest.

[84]  A. Arroliga,et al.  Alveolar hemorrhage in patients with rheumatic disease. , 1997, Rheumatic diseases clinics of North America.

[85]  F. Craig,et al.  Malignancy-associated pulmonary veno-occlusive disease: report of a case following autologous bone marrow transplantation and review. , 1996, Bone marrow transplantation.

[86]  B. Groves,et al.  A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. , 1996, The New England journal of medicine.

[87]  V. Steen,et al.  Autoantibodies in systemic sclerosis. , 1996, Bulletin on the rheumatic diseases.

[88]  W. Summer,et al.  Effect of prostacyclin on microvascular pressures in a patient with pulmonary veno-occlusive disease. , 1995, Chest.

[89]  X. Mariette,et al.  Recovery from pulmonary hypertension with steroid therapy in a patient with Sjögren's syndrome and polymyositis. , 1994, The Journal of rheumatology.

[90]  G. Pietra.  Histopathology of primary pulmonary hypertension. , 1994, Chest.

[91]  C. Milgrom,et al.  A REPORT OF FOUR CASES , 1994 .

[92]  R. Priori,et al.  Pulmonary Arterial Hypertension Responsive to Immunosuppressive Therapy in Systemic Lupus Erythematosus , 1993, Lupus.

[93]  Y. Hosoda,et al.  Pulmonary venoocclusive disease in a patient with systemic lupus erythematosus. , 1993, The Journal of rheumatology.

[94]  A. Gibbs,et al.  Pulmonary veno-occlusive disease and Hodgkin's lymphoma. , 1993, The European respiratory journal.

[95]  Smith Cd,et al.  Pulmonary veno-occlusive disease and the CREST variant of scleroderma. , 1992 .

[96]  D. Gladman,et al.  HLA alleles in systemic sclerosis: association with pulmonary hypertension and outcome. , 1992, British journal of rheumatology.

[97]  C. D. Smith,et al.  Pulmonary veno-occlusive disease and the CREST variant of scleroderma. , 1992, The Canadian journal of cardiology.

[98]  P. Nicod,et al.  Primary pulmonary hypertension. The risk and benefit of lung biopsy. , 1989, Circulation.

[99]  B. Groves,et al.  Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry. , 1989, Circulation.

[100]  P. Hasleton,et al.  Pulmonary veno‐occlusive disease. A report of four cases , 1986, Histopathology.

[101]  G. Wilson,et al.  Fatal pulmonary hypertension following renal transplantation. , 1985, British journal of diseases of the chest.